A Dutch advocacy group claims that women receive worse care than men, because pharmaceutical companies do not sufficiently test their medicines on women. A shocking …

By Lucien Hordijk & Daan Marselis Most of the demand for (refresher) training courses for doctors in the Netherlands is fulfilled by industry- sponsored programmes. …

Two decades of EU market protection of ‘orphan’ (rare disease) medicines have greatly benefitted the industry. According to research by The Investigative Desk, published in …